Results 191 to 200 of about 22,723 (239)

Inhibition of protein misfolding/aggregation using polyglutamine binding peptide QBP1 as a therapy for the polyglutamine diseases. [PDF]

open access: yesNeurotherapeutics, 2013
Popiel HA   +6 more
europepmc   +1 more source

Establishment of a second-generation transgenic marmoset with germline transmission that models polyglutamine disease

open access: yesDisease Models & Mechanisms
Eiko N. Minakawa   +18 more
doaj   +1 more source

The Status and Future Directions of Treatments for Polyglutamine Spinocerebellar Ataxia: A Bibliometric and Visual Analysis. [PDF]

open access: yesCurr Neuropharmacol
Ding S   +9 more
europepmc   +1 more source

Hypothalamic Atrophy and Textural Changes in Polyglutamine Ataxias. [PDF]

open access: yesCerebellum
Rodrigues L   +9 more
europepmc   +1 more source

Unveiling a Rare Phenotypic Presentation of Mitofusin 2 Mutation as Cerebellar Ataxia. [PDF]

open access: yesAnn Indian Acad Neurol
Robert P   +3 more
europepmc   +1 more source

Hereditary Ataxias: From Pathogenesis and Clinical Features to Neuroimaging, Fluid, and Digital Biomarkers-A Scoping Review. [PDF]

open access: yesInt J Mol Sci
Bernardi E   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy